CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction

Biochemical and Biophysical Research Communications

Volumn 424, Issue 3, 2012, Pages 456-461

  Oue, Erika ^a   Lee, Ji Won ^a   Sakamoto, Kei ^a   Iimura, Tadahiro ^a   Aoki, Kazuhiro ^a   Kayamori, Kou ^a,b   Michi, Yasuyuki ^a   Yamashiro, Masashi ^a   Harada, Kiyoshi ^a   Amagasa, Teruo ^a   Yamaguchi, Akira ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ome Municipal General Hospital   (Japan)

Author keywords

Bone resorption; CXCL2; Oral cancer; Osteoclast; RANKL

Indexed keywords

CXCL2 CHEMOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE MARROW CELL; CANCER CELL CULTURE; CELL COUNT; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MOLECULAR CLONING; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT;

ANIMALS; BONE RESORPTION; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHEMOKINE CXCL2; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; HUMANS; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND;

MUS;

EID: 84864759030     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.132     Document Type: Article

References (20)

1. Semba I., Matsuuchi H., Miura Y. Histomorphometric analysis of osteoclastic resorption in bone directly invaded by gingival squamous cell carcinoma. J. Oral Pathol. Med. 1996, 25:429-435.
2. Brown J.S., Lowe D., Kalavrezos N., D'Souza J., Magennis P., Woolgar J. Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma. Head Neck 2002, 24:370-383.
3. Shaw R.J., Brown J.S., Woolgar J.A., Lowe D., Rogers S.N., Vaughan E.D. The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck 2004, 26:861-869.
4. Ishikuro M., Sakamoto K., Kayamori K., Akashi T., Kanda H., Izumo T., Yamaguchi A. Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas. Bone 2008, 43:621-627.
5. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. 1998, 95:3597-3602.
6. Boyce B.F., Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 2008, 473:139-146.
7. Okamoto M., Hiura K., Ohe G., Ohba Y., Terai K., Oshikawa T., Furuichi S., Nishikawa H., Moriyama K., Yoshida H., Sato M. Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Cancer 2000, 89:1966-1975.
8. Tada T., Jimi E., Okamoto M., Ozeki S., Okabe K. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of os-teoprotegerin expression in osteoblasts. Int. J. Cancer 2005, 116:253-262.
9. Shibahara T., Nomura T., Cui N., Noma H. A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma. Int. J. Oral Maxillofac. Surg. 2005, 34:789-793.
10. Ono K., Akatsu T., Kugai N., Pilbeam C.C., Raisz L.G. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines1. Bone 2003, 33:798-804.
11. Jimi E., Furuta H., Matsuo K., Tominaga K., Takahashi T., Nakanishi O. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma. Oral Dis. 2011, 17:462-468.
12. Kayamori K., Sakamoto K., Nakashima T., Takayanagi H., Morita K., Omura K., Nguyen S.T., et al. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am. J. Pathol. 2010, 176:968-980.
13. Momose F., Araida T., Negishi A., Ichijo H., Shioda S., Sasaki S. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J. Oral Pathol. Med. 1989, 18:391-395.
14. Li X., Klintman D., Liu Q., Sato T., Jeppsson B., Thorlacius H. Critical role of CXC chemokines in endotoxemic liver injury in mice. J. Leukoc. Biol. 2004, 75:443-452.
15. Ren X., Carpenter A., Hogaboam C., Colletti L. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am. J. Pathol. 2003, 163:563-570.
16. Ha J., Choi H., Lee Y., Kwon H., Song Y.W., Kim H. CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis. J. Immunol. 2010, 184:4717-4724.
17. Ha J., Lee Y., Kim H. CXCL2 mediates lipopolysaccharide-induced osteoclastogenesis in RANKL-primed precursors. Cytokine 2011, 55:48-55.
18. Dong Q., Zhang J., Li Q., Bracher J.C., Hendricks D.T., Zhao X. Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma. World J. Gastroenterol. 2011, 17:2658-2662.
19. Dong Q., Zhang J., Hendricks D.T., Zhao X. GROβ and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells. Oncol. Rep. 2011, 25:1031-1037.
20. Yamada T., Tsuda M., Takahashi T., Totsuka Y., Shindoh M., Ohba Y. RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression. Am. J. Pathol. 2011, 178:2845-2856.